3D Bioprinting Market by Technology (Microextrusion, Inkjet, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

  • ID: 4328403
  • Report
  • Region: Global
  • 145 Pages
  • Markets and Markets
1 of 6
The Global 3D Bioprinting Market is Expected to Reach USD 1,332.6 Million by 2021 from USD 411.4 Million in 2016 at a CAGR of 26.5% between 2016 and 2021

FEATURED COMPANIES

  • 3Dynamic Systems Ltd.
  • Aspect Biosystems Ltd.
  • Biobots
  • Cellink
  • Cyfuse Biomedical K.K.
  • Envisiontec GmbH
  • MORE

The 3D bioprinting market is primarily driven by the rising demand for organ transplantation across the globe. In addition, growing R&D in the field of 3D bioprinting, increasing public and private investments to support 3D bioprinting research, and rising use of 3D bioprinting in drug discovery are supporting the growth of this market. On the other hand, limitations of biomaterial-based products and socio-ethical concerns are the major challenges in this market.

In this report, the 3D bioprinting market has been segmented on the basis of technology, applications (clinical and research applications), materials (living cells, hydrogels, extracellular matrices, and other biomaterials), and regions (North America, Europe, APAC, and the RoW). By technology, the global 3D bioprinting market is segmented into four categories, namely, microextrusion, laser-assisted, inkjet, and magnetic 3D bioprinting. The microextrusion 3D bioprinting market is estimated to command the largest share of the global market in 2016, due to its high affordability and simple setup process.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the 3D bioprinting market in 2016, followed by Europe. Increasing government initiatives and rising demand for organ transplants are the major factors driving market growth in North America. However, the presence of a stringent regulatory process for the approval of 3D bioprinting products is a major factor restraining the growth of this regional segment.

The 3D bioprinting market consists of a number of big, medium-sized, and small companies. As of 2015, the syringes market is dominated by Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), and Nano3D Biosciences, Inc. (U.S.). Product launches, development, and commercialization; agreements; collaboration; and partnerships were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the 3D bioprinting market.

Research Coverage

This report studies the 3D bioprinting market based on technology, application, and material. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

This research report focuses on various levels of analysis - industry trends, market ranking of top players, and company profiles - which together discuss basic views on the competitive landscape, emerging and high-growth segments of the 3D bioprinting market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening its market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products and services offered by major players in the 3D bioprinting market. The report analyzes the 3D bioprinting market based on technology, application, material, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the 3D bioprinting market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various 3D bioprinting products across geographies
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the 3D bioprinting market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products & services, distribution networks, and manufacturing capabilities of leading players in the 3D bioprinting market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 3Dynamic Systems Ltd.
  • Aspect Biosystems Ltd.
  • Biobots
  • Cellink
  • Cyfuse Biomedical K.K.
  • Envisiontec GmbH
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.5 Years Considered for the Study
1.6 Currency
1.7 Limitations
1.8 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.1.1 Secondary and Primary Research Methodology
2.1.1.1 Secondary Research
2.1.1.2 Key Data From Secondary Sources
2.1.1.3 Primary Research
2.1.1.4 Key Data From Primary Sources
2.1.1.5 Key Industry Insights
2.2 Market Size Estimation Methodology
2.3 Research Design
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 3D Bioprinting: Market Overview
4.2 Geographic Analysis: 3D Bioprinting Market, By Technology (2016)
4.3 Market Size, By Material, 2016 vs 2021 (USD Million)
4.4 Market Size, By Application, 2016 vs 2021 (USD Million)
4.5 Geographic Snapshot of the 3D Bioprinting Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Demand for Organ Transplantation
5.2.1.2 Rise in Public and Private Funding to Support 3D Bioprinting Research Activities
5.2.1.3 Increasing Use of 3D Bioprinting in the Drug Discovery Process
5.2.1.4 Growing Focus of Market Players on 3D Bioprinting
5.2.2 Restraints
5.2.2.1 Lack of Regulatory Guidelines Governing 3D Bioprinting
5.2.2.2 Dearth of Trained Professionals
5.2.3 Opportunities
5.2.3.1 Increasing Stem Cell Research
5.2.3.2 Growing Awareness Related to 3D Bioprinting
5.2.3.3 Rising Adoption of 3D Bioprinting in the Cosmetic Industry
5.2.4 Challenges
5.2.4.1 Socio-Ethical Concerns Related to the Use of 3D Bioprinted Products
5.2.4.2 Limitations of Biomaterial-Based Products
5.2.4.3 Lack of Complete Automation

6 Industry Insights
6.1 Introduction
6.2 3D Bioprinting Approaches
6.2.1 Biomimicry
6.2.2 Autonomous Self-Assembly
6.2.3 Mini-Tissue Building Blocks
6.3 3D Bioprinting Patent Landscape
6.4 Industry Trends
6.4.1 Funding and Investments
6.4.2 Partnerships, Agreements, and Collaborations
6.4.3 Conferences and Symposiums

7 3D Bioprinting Market, By Technology
7.1 Introduction
7.2 Magnetic 3D Bioprinting
7.3 Laser-Assisted Bioprinting
7.4 Inkjet 3D Bioprinting
7.5 Microextrusion Bioprinting

8 3D Bioprinting Market, By Material
8.1 Introduction
8.2 Hydrogels
8.3 Extracellular Matrices
8.4 Living Cells
8.5 Other Biomaterials

9 3D Bioprinting Market, By Application
9.1 Introduction
9.2 Clinical Applications
9.2.1 Skin
9.2.2 Bone & Cartilage
9.2.3 Blood Vessels
9.3 Research Applications
9.3.1 Drug Research
9.3.2 Regenerative Medicine
9.3.3 3D Cell Culture

10 Market By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Overview
11.2 Market Ranking Analysis
11.3 Competitive Situation and Trends
11.3.1 Agreements, Partnerships, & Collaborations
11.3.2 Product Launches, Developments, and Commercialization
11.3.3 Product Showcases, Exhibitions, and Presentations
11.3.4 Funding
11.3.5 Other Strategies

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments)*
12.1 Introduction
12.2 Organovo Holdings, Inc.
12.3 Envisiontec GmbH
12.4 Nano 3D Biosciences, Inc.
12.5 Cyfuse Biomedical K.K.
12.6 Regenhu Ltd.
12.7 Aspect Biosystems Ltd.
12.8 Biobots
12.9 Cellink
12.10 Gesim
12.11 Poietis
12.12 Regenovo Biotechnology Co., Ltd.
12.13 3Dynamic Systems Ltd.

*Details on  Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Discussion Guide

List of Tables

Table 1 3D Bioprinting Patents, 2015-2016
Table 2 3D Bioprinting Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Magnetic 3D Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 4 Laser-Assisted 3D Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 5 Inkjet 3D Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 6 Microextrusion 3D Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 7 3D Bioprinting Market Size, By Material, 2014-2021 (USD Million)
Table 8 Hydrogels Market Size, By Region, 2014-2021 (USD Million)
Table 9 Extracellular Matrices Market Size, By Region, 2014-2021 (USD Million)
Table 10 Living Cells Market Size, By Region, 2014-2021 (USD Million)
Table 11 Other Biomaterials Market Size, By Region, 2014-2021 (USD Million)
Table 12 3D Bioprinting Market Size, By Application, 2014-2021 (USD Million)
Table 13 Clinical Applications Market Size, By Type, 2014-2021 (USD Million)
Table 14 Clinical Applications Market Size, By Region, 2014-2021 (USD Million)
Table 15 Skin Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 16 Bone & Cartilage Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 17 Blood Vessel Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 18 Research Applications Market Size, By Type, 2014-2021 (USD Million)
Table 19 Research Applications Market Size, By Region, 2014-2021 (USD Million)
Table 20 Drug Research Market Size, By Region, 2014-2021 (USD Million)
Table 21 Regenerative Medicine Market Size, By Region, 2014-2021 (USD Million)
Table 22 3D Cell Culture Market Size, By Region, 2014-2021 (USD Million)
Table 23 3D Bioprinting Market Size, By Region, 2014-2021 (USD Million)
Table 24 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 25 North America: Market Size, By Technology, 2014-2021 (USD Million)
Table 26 North America: Market Size, By Application, 2014-2021 (USD Million)
Table 27 North America: Market Size, By Material, 2014-2021 (USD Million)
Table 28 U.S.: Market Size, By Technology, 2014-2021 (USD Million)
Table 29 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 30 U.S.: Market Size, By Material, 2014-2021 (USD Million)
Table 31 Canada: Market Size, By Technology, 2014-2021 (USD Million)
Table 32 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 33 Canada: Market Size, By Material, 2014-2021 (USD Million)
Table 34 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 35 Europe: Market Size, By Technology, 2014-2021 (USD Million)
Table 36 Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 37 Europe: Market Size, By Material, 2014-2021 (USD Million)
Table 38 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 39 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 40 Germany: Market Size, By Material, 2014-2021 (USD Million)
Table 41 France: Market Size, By Technology, 2014-2021 (USD Million)
Table 42 France: Market Size, By Application, 2014-2021 (USD Million)
Table 43 France: Market Size, By Material, 2014-2021 (USD Million)
Table 44 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 45 U.K.: Market Size, By Application, 2014-2021 (USD Million)
Table 46 U.K.: Market Size, By Material, 2014-2021 (USD Million)
Table 47 RoE: Market Size, By Technology, 2014-2021 (USD Million)
Table 48 RoE: Market Size, By Application, 2014-2021 (USD Million)
Table 49 RoE: Market Size, By Material, 2014-2021 (USD Million)
Table 50 Asia-Pacific: 3D Bioprinting Market Size, By Country, 2014-2021 (USD Million)
Table 51 Asia-Pacific: Market Size, By Technology, 2014-2021 (USD Million)
Table 52 Asia-Pacific: Market Size, By Application, 2014-2021 (USD Million)
Table 53 Asia-Pacific: Market Size, By Material, 2014-2021 (USD Million)
Table 54 Japan: Market Size, By Technology, 2014-2021 (USD Million)
Table 55 Japan: Market Size, By Application, 2014-2021 (USD Million)
Table 56 Japan: Market Size, By Material, 2014-2021 (USD Million)
Table 57 China: Market Size, By Technology, 2014-2021 (USD Million)
Table 58 China: Market Size, By Application, 2014-2021 (USD Million)
Table 59 China: Market Size, By Material, 2014-2021 (USD Million)
Table 60 India: Market Size, By Technology, 2014-2021 (USD Million)
Table 61 India:  Market Size, By Application, 2014-2021 (USD Million)
Table 62 India: Market Size, By Material, 2014-2021 (USD Million)
Table 63 RoAPAC: Market Size, By Technology, 2014-2021 (USD Million)
Table 64 RoAPAC: Market Size, By Application, 2014-2021 (USD Million)
Table 65 RoAPAC: Market Size, By Material, 2014-2021 (USD Million)
Table 66 RoW: Market Size, By Technology, 2014-2021 (USD Million)
Table 67 RoW: Market Size, By Application, 2014-2021 (USD Million)
Table 68 RoW: Market Size, By Material, 2014-2021 (USD Million)
Table 69 Agreements, Partnerships, and Collaborations, 2013-2016
Table 70 Top 5 Product Launches, Developments, and Commercialization, 2013-2016
Table 71 Product Showcases, Exhibitions, and Presentations, 2013-2016
Table 72 Top 5 Funding, 2013-2016
Table 73 Other Strategies, 2013-2016
Table 74 Product Mix of the 3D Bioprinter Market Players

List of Figures

Figure 1 Global 3D Bioprinting Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Bottom-Up Approach
Figure 4 Research Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Data Triangulation Methodology
Figure 7 Global 3D Bioprinting Market, By Technology
Figure 8 Global Market, By Application
Figure 9 Global Market, By Material
Figure 10 Geographic Snapshot of the Global Market
Figure 11 Rising Demand for Organ Transplantation is Driving Growth in the 3D Bioprinting Market
Figure 12 Microextrusion 3D Bioprinting to Dominate the Global Market in 2016
Figure 13 Living Cells to Command the Largest Share in the 3D Bioprinting Market in 2016
Figure 14 Research Applications Will Continue to Dominate the Global Market in 2021
Figure 15 North America to Command the Largest Share in the Global Market in 2016
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Microextrusion 3D Bioprinting Segment to Witness High Growth During the Forecast Period
Figure 18 Asia-Pacific to Witness High Growth During the Forecast Period
Figure 19 North America to Hold A Major Share in the Laser-Assisted 3D Bioprinting Market
Figure 20 Asia-Pacific to Witness High Growth During the Forecast Period
Figure 21 North America to Hold A Major Share in the Microextrusion 3D Bioprinting Market
Figure 22 Living Cells Segment to Register Highest Growth During the Forecast Period
Figure 23 North America to Hold the Largest Share in the Hydrogels Market, in 2016 and 2021
Figure 24 Asia-Pacific Segment to Register Highest Growth During the Forecast Period
Figure 25 North America to Hold the Largest Share in the Living Cells Market During the Forecast Period
Figure 26 North America to Hold Largest Share of the Other Biomaterials Market in 2016
Figure 27 Research Applications Segment to Witness Highest Growth During the Forecast Period
Figure 28 Skin Segment to Register Highest Growth During the Forecast Period
Figure 29 North America to Command Largest Share During the Forecast Period
Figure 30 Drug Research Segment to Register Highest Growth During the Forecast Period
Figure 31 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 32 Market Growth Forecast, By Region (2016-2021)
Figure 33 North America: 3D Bioprinting Market Snapshot
Figure 34 Europe: Market Snapshot
Figure 35 APAC: Market Snapshot
Figure 36 Leading Market Players Adopted Agreement, Collaboration, and Partnership as Their Key Growth Strategy Over the Last Three Years (2013-2016)
Figure 37 Market Ranking By Key Player, 2015
Figure 38 Battle for Market Share: Agreement, Collaboration, and Partnership Was the Key Strategy Adopted By Market Players
Figure 39 Company Snapshot: Organovo Holdings, Inc.

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • 3Dynamic Systems Ltd.
  • Aspect Biosystems Ltd.
  • Biobots
  • Cellink
  • Cyfuse Biomedical K.K.
  • Envisiontec GmbH
  • Gesim
  • Nano 3D Biosciences, Inc.
  • Organovo Holdings, Inc.
  • Poietis
  • Regenhu Ltd.
  • Regenovo Biotechnology Co., Ltd.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll